# Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

> **NCT03433274** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abbott Medical Devices** · enrollment: 103 (actual)

## Conditions studied

- Mitral Regurgitation
- Mitral Insufficiency
- Mitral Valve Insufficiency
- Cardiovascular Diseases
- Valve Disease, Heart
- Heart Valve Diseases
- Functional Mitral Regurgitation
- Degenerative Mitral Valve Disease

## Interventions

- **DEVICE:** Tendyne Mitral Valve System
- **DEVICE:** MitraClip System

## Key facts

- **NCT ID:** NCT03433274
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-06-15
- **Primary completion:** 2024-04-29
- **Final completion:** 2028-06
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03433274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03433274, "Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03433274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*